Nuzenio

Mutant Nsclc Management

Mutant Nsclc Management news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Benjamin P. Levy, MD, on KRAS G12C–Mutated NSCLC: Current Treatment Landscape - The ASCO PostThe ASCO Post · Sun, 09 Aug 2026 02:02:31 GMT Treatment Strategies Following Progression in EGFR-Mutant NSCLC - OncLiveOncLive · Fri, 07 Aug 2026 01:41:15 GMT Risk Stratification and Treatment Selection in EGFR-Mutant NSCLC - OncLiveOncLive · Thu, 06 Aug 2026 19:45:26 GMT Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - PR NewswirePR Newswire · Mon, 03 Aug 2026 11:45:00 GMT Herbert Loong: EGFR-Mutant NSCLC Management in the Era of FLAURA2 and MARIPOSA - OncodailyOncodaily · Sun, 02 Aug 2026 20:14:50 GMT Leptomeningeal Disease Management in EGFR-Mutated NSCLC: Systemic Therapy, Radiation, and Intrathecal Options - OncLiveOncLive · Tue, 28 Jul 2026 13:32:05 GMT

Timeline

Sun, 09 Aug 2026 02:02:31 GMTBenjamin P. Levy, MD, on KRAS G12C–Mutated NSCLC: Current Treatment Landscape - The ASCO Post

Fri, 07 Aug 2026 01:41:15 GMTTreatment Strategies Following Progression in EGFR-Mutant NSCLC - OncLive

Thu, 06 Aug 2026 19:45:26 GMTRisk Stratification and Treatment Selection in EGFR-Mutant NSCLC - OncLive

Mon, 03 Aug 2026 11:45:00 GMTLilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - PR Newswire

Sun, 02 Aug 2026 20:14:50 GMTHerbert Loong: EGFR-Mutant NSCLC Management in the Era of FLAURA2 and MARIPOSA - Oncodaily

Tue, 28 Jul 2026 13:32:05 GMTLeptomeningeal Disease Management in EGFR-Mutated NSCLC: Systemic Therapy, Radiation, and Intrathecal Options - OncLive

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

EGFR8 live mentions KRAS4 live mentions Mutated NSCLC4 live mentions The ASCO Post3 live mentions OncLive3 live mentions Benjamin P2 live mentions Levy2 live mentions Current Treatment Landscape2 live mentions Mutant NSCLC2 live mentions Mutant NSCLC OncLive2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mutant Nsclc Management.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.